These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11332588)

  • 1. Influence of the hormonal status on somatic, psychopathological and mood symptoms in climacteric women.
    Di Nicola V; Chiechi LM; Lobascio A; Todarello O
    Clin Exp Obstet Gynecol; 2001; 28(1):43-6. PubMed ID: 11332588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life.
    Toffol E; Kalleinen N; Haukka J; Vakkuri O; Partonen T; Polo-Kantola P
    Menopause; 2014 May; 21(5):493-500. PubMed ID: 24065140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexuality.
    Genazzani AR; Stomati M; Valentino V; Pluchino N; Pot E; Casarosa E; Merlini S; Giannini A; Luisi M
    Climacteric; 2011 Dec; 14(6):661-8. PubMed ID: 21942655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution.
    Genazzani AR; Gambacciani M
    Gynecol Endocrinol; 2006 Mar; 22(3):145-50. PubMed ID: 16835076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormones and psychological functioning in postmenopausal women.
    Sherwin BB
    Exp Gerontol; 1994; 29(3-4):423-30. PubMed ID: 7925760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5HTT and MAO-A polymorphisms associate with depressive mood and climacteric symptoms in postmenopausal women.
    Grochans E; Grzywacz A; Jurczak A; Samochowiec A; Karakiewicz B; Brodowska A; Starczewski A; Samochowiec J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():125-30. PubMed ID: 23707423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal women.
    Wihlbäck AC; Nyberg S; Bäckström T; Bixo M; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Jan; 30(1):38-50. PubMed ID: 15358441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormones, the menopause, sexuality and well-being of women.
    Cawood EH; Bancroft J
    Psychol Med; 1996 Sep; 26(5):925-36. PubMed ID: 8878326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and menopausal status as predictors of depression in women in transition to menopause.
    Freeman EW; Sammel MD; Liu L; Gracia CR; Nelson DB; Hollander L
    Arch Gen Psychiatry; 2004 Jan; 61(1):62-70. PubMed ID: 14706945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Controversial issues in climacteric medicine" series 3rd Pisa workshop "HRT in climacteric and aging brain". Pisa, Italy, 15-18 March 2003.
    Genazzani AR; Gambacciani M; Simoncini T; Schneider HP;
    Maturitas; 2003 Sep; 46(1):7-26. PubMed ID: 12963166
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasomotor symptoms and well-being in the climacteric years.
    Groeneveld FP; Bareman FP; Barentsen R; Dokter HJ; Drogendijk AC; Hoes AW
    Maturitas; 1996 Apr; 23(3):293-9. PubMed ID: 8794423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wellness in women after 40 years of age: the role of sex hormones and pheromones.
    Cutler WB; Genovese-Stone E
    Dis Mon; 1998 Sep; 44(9):421-546. PubMed ID: 9803240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care.
    Joffe H; Hall JE; Soares CN; Hennen J; Reilly CJ; Carlson K; Cohen LS
    Menopause; 2002; 9(6):392-8. PubMed ID: 12439097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Official position of the Chilean Society of Climacteric on the management of climacteric women].
    Blümel JE; Aravena H; Brantes S; Cruzat L; Lavín P; Montaño R; Navarrete I; Osorio E
    Rev Med Chil; 2010 May; 138(5):645-51. PubMed ID: 20668822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived effects of testosterone replacement therapy in perimenopausal and postmenopausal women: an internet pilot study.
    Davis A; Gilbert K; Misiowiec P; Riegel B
    Health Care Women Int; 2003 Nov; 24(9):831-48. PubMed ID: 14742120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status.
    Travers C; O'Neill SM; King R; Battistutta D; Khoo SK
    Climacteric; 2005 Mar; 8(1):56-62. PubMed ID: 15804732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hormonal adaptation in the climacteric and the question of hormone therapy in postmenopause].
    Kyank H
    Z Alternsforsch; 1966 Dec; 19(3):305-16. PubMed ID: 4294394
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrinological view of ageing and climacteric syndrome in women.
    Donát J; Jirkalová V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(5):603-47. PubMed ID: 6599826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.